CHOOLIP & SCIENCES Inc. (KOSDAQ: A291650)
Health Care · Biotechnology · KR
₩1,980.00
+18.14% today · -15.0% 1Y
CHOOLIP & SCIENCES Inc. (KOSDAQ: A291650) operates in the Biotechnology industry within the Health Care sector. The company is valued at $43.60M.
Over the last twelve months the share price has lost 15.0%, trading between 1.35K and 4.00K.
A291650 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $43.60M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- —
- Dividend yield
- —
- Beta (5Y)
- -0.19
- 52-week high
- ₩3,996.00
- 52-week low
- ₩1,350.00
- Avg volume (3M)
- —
- Shares outstanding
- 30.52M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $469.68B | $260.95 | -1.82% |
| Amgen Inc.NasdaqGS: AMGN | $239.09B | $442.16 | -0.02% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $184.47B | $148.74 | -0.02% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $140.13B | $551.22 | -0.29% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.24B | $823.30 | -1.23% |
| argenx SEENXTBR: ARGX | $64.17B | €897.60 | +2.09% |
| Moderna, Inc.NasdaqGS: MRNA | $63.41B | $147.72 | -6.99% |
| CSL LimitedASX: CSL | $59.49B | AU$173.64 | +2.68% |
Figures last refreshed Aug 18, 2026.